Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of “Buy” from Analysts

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has been assigned an average rating of “Buy” from the seven research firms that are covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have updated their coverage on the […]

Leave a Reply

Your email address will not be published.

Previous post Fortinet (NASDAQ:FTNT) Rating Reiterated by Needham & Company LLC
Next post Sensata Technologies Holding plc (NYSE:ST) Given Average Recommendation of “Hold” by Brokerages